Citation Tools
PDFRegular and young investigator award abstracts
Checkpoint blockade therapy
203 Preclinical characterization and development of MG1124, a Novel Immune Checkpoint inhibitor targeting CEACAM1 for NSCLC patients
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- 203 Preclinical characterization and development of MG1124, a Novel Immune Checkpoint inhibitor targeting CEACAM1 for NSCLC patients